Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Livermore

Showing results (41-50 of 963) with videos related to

Pageof 97
Sort By:
Science (New York, N.Y.)|September 2, 1977
Technology topic of pacific science association meetingA H Livermore
Diagnostic Microbiology and Infectious Disease|March 24, 2009
Doripenem: antimicrobial profile and clinical potentialDavid M Livermore
The Journal of Antimicrobial Chemotherapy|October 10, 2008
Future directions with daptomycinDavid M Livermore
The Journal of Antimicrobial Chemotherapy|June 25, 2011
Discovery research: the scientific challenge of finding new antibioticsDavid M Livermore,
Clinical Microbiology Reviews|October 1, 1995
beta-Lactamases in laboratory and clinical resistanceD M Livermore
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1996
Are all beta-lactams created equal?D M Livermore
The Journal of Antimicrobial Chemotherapy|August 4, 1998
Beta-lactamase-mediated resistance and opportunities for its controlD M Livermore
Drugs|January 1, 1987
Mechanisms of resistance to cephalosporin antibioticsD M Livermore
AACN Advanced Critical Care|December 8, 2021
COVID-19-Associated Pulmonary Aspergillosis in the Critical Care SettingJennifer M Livermore
The Journal of Antimicrobial Chemotherapy|February 27, 2001
Of Pseudomonas, porins, pumps and carbapenemsD M Livermore
Pageof 97

Showing results (41-50 of 963) with videos related to

Sort By:
Pageof 97
Science (New York, N.Y.)|September 2, 1977
Technology topic of pacific science association meetingA H Livermore
Diagnostic Microbiology and Infectious Disease|March 24, 2009
Doripenem: antimicrobial profile and clinical potentialDavid M Livermore
The Journal of Antimicrobial Chemotherapy|October 10, 2008
Future directions with daptomycinDavid M Livermore
The Journal of Antimicrobial Chemotherapy|June 25, 2011
Discovery research: the scientific challenge of finding new antibioticsDavid M Livermore,
Clinical Microbiology Reviews|October 1, 1995
beta-Lactamases in laboratory and clinical resistanceD M Livermore
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1996
Are all beta-lactams created equal?D M Livermore
The Journal of Antimicrobial Chemotherapy|August 4, 1998
Beta-lactamase-mediated resistance and opportunities for its controlD M Livermore
Drugs|January 1, 1987
Mechanisms of resistance to cephalosporin antibioticsD M Livermore
AACN Advanced Critical Care|December 8, 2021
COVID-19-Associated Pulmonary Aspergillosis in the Critical Care SettingJennifer M Livermore
The Journal of Antimicrobial Chemotherapy|February 27, 2001
Of Pseudomonas, porins, pumps and carbapenemsD M Livermore
Pageof 97